These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 32382893)
21. Long-term outcomes of salvage endoscopic submucosal dissection for local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Kimura H; Yoshida M; Yabuuchi Y; Kakushima N; Yamamoto Y; Kawata N; Takizawa K; Kishida Y; Imai K; Ito S; Hotta K; Ishiwatari H; Matsubayashi H; Ono H Jpn J Clin Oncol; 2021 Jul; 51(7):1036-1043. PubMed ID: 33758950 [TBL] [Abstract][Full Text] [Related]
22. Salvage lymphadenectomy versus salvage radiotherapy/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma. Ma X; Zhao K; Guo W; Yang S; Zhu X; Xiang J; Zhang Y; Li H Ann Surg Oncol; 2015 Feb; 22(2):624-9. PubMed ID: 25155397 [TBL] [Abstract][Full Text] [Related]
23. Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer. Farinella E; Safar A; Nasser HA; Bouazza F; Liberale G; Paesmans M; Marechal R; Van Laethem JL; Hendlisz A; VanHoutte P; El Nakadi I J Surg Oncol; 2016 Dec; 114(7):833-837. PubMed ID: 27778349 [TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy. Hayami M; Watanabe M; Ishizuka N; Mine S; Imamura Y; Okamura A; Kurogochi T; Yamashita K J Surg Oncol; 2018 May; 117(6):1251-1259. PubMed ID: 29205358 [TBL] [Abstract][Full Text] [Related]
25. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone. Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212 [TBL] [Abstract][Full Text] [Related]
26. Salvage Surgery for Recurrent Disease after Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. Miyata H; Sugimura K; Kanemura T; Takeoka T; Sugase T; Tanaka K; Makino T; Yamashita K; Yamasaki M; Motoori M; Shiraishi O; Kimura Y; Yasuda T; Yano M; Doki Y Ann Surg Oncol; 2022 Sep; 29(9):5657-5665. PubMed ID: 35536523 [TBL] [Abstract][Full Text] [Related]
27. Salvage esophagectomy after exclusive chemoradiotherapy: results at the Brazilian National Cancer Institute (INCA). Pinto CE; Fernandes Dde S; Sá EA; Mello EL Dis Esophagus; 2009; 22(8):682-6. PubMed ID: 19302224 [TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy. Ego M; Abe S; Nakatani Y; Nonaka S; Suzuki H; Yoshinaga S; Oda I; Kato K; Honma Y; Itami J; Daiko H; Saito Y; Boku N Surg Endosc; 2021 Apr; 35(4):1766-1776. PubMed ID: 32356109 [TBL] [Abstract][Full Text] [Related]
29. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy. Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181 [TBL] [Abstract][Full Text] [Related]
30. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial). Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448 [TBL] [Abstract][Full Text] [Related]
31. Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. Morita M; Kumashiro R; Hisamatsu Y; Nakanishi R; Egashira A; Saeki H; Oki E; Ohga T; Kakeji Y; Tsujitani S; Yamanaka T; Maehara Y J Gastroenterol; 2011 Nov; 46(11):1284-91. PubMed ID: 21818602 [TBL] [Abstract][Full Text] [Related]
32. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer. Hattori S; Muto M; Ohtsu A; Boku N; Manabe T; Doi T; Ishikura S; Yoshida S Gastrointest Endosc; 2003 Jul; 58(1):65-70. PubMed ID: 12838223 [TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma. Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451 [TBL] [Abstract][Full Text] [Related]
34. Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol. Chang X; Deng L; Ni W; Li C; Han W; Gao LR; Wang S; Zhou Z; Chen D; Feng Q; Liang J; Bi N; Lv J; Gao S; Mao Y; Xue Q; Xiao Z BMC Cancer; 2020 Sep; 20(1):877. PubMed ID: 32928136 [TBL] [Abstract][Full Text] [Related]